Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H24N4O2 |
Molecular Weight | 424.4944 |
Optical Activity | NONE |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@]1(O)C[C@@](N)(C1)C2=CC=C(C=C2)C3=C(N4COC5=C(C=NC=C5)C4=N3)C6=CC=CC=C6
InChI
InChIKey=AIFGVDXMHWGOGJ-DIVCQZSQSA-N
InChI=1S/C26H24N4O2/c1-25(31)14-26(27,15-25)19-9-7-17(8-10-19)22-23(18-5-3-2-4-6-18)30-16-32-21-11-12-28-13-20(21)24(30)29-22/h2-13,31H,14-16,27H2,1H3/t25-,26-
Molecular Formula | C26H24N4O2 |
Molecular Weight | 424.4944 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:59:13 GMT 2023
by
admin
on
Sat Dec 16 14:59:13 GMT 2023
|
Record UNII |
QI52W1ZIIB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB15054
Created by
admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
|
PRIMARY | |||
|
300000026356
Created by
admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
|
PRIMARY | |||
|
QI52W1ZIIB
Created by
admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
|
PRIMARY | |||
|
C178300
Created by
admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
|
PRIMARY | |||
|
1402602-94-1
Created by
admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
|
PRIMARY | |||
|
12291
Created by
admin on Sat Dec 16 14:59:13 GMT 2023 , Edited by admin on Sat Dec 16 14:59:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
ALLOSTERIC INHIBITOR
IC50
|
||
|
TARGET -> INHIBITOR |
ALLOSTERIC INHIBITOR
IC50
|
||
|
TARGET -> INHIBITOR |
ALLOSTERIC INHIBITOR
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Originator: Taiho Pharmaceutical; Class: Antineoplastic; Mechanism of Action: Proto oncogene protein c-akt inhibitor; Orphan Drug Status: No; On Fast track: No; New Molecular Entity: Yes;
Highest Development Phase: Phase I for Solid tumours; Most Recent Event: 01 Feb 2015 Phase-I clinical trials in Solid tumours (Late-stage disease, Metastatic disease) in Japan (PO)(JapicCTI152780)
|